Compare PHAR & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | ASST |
|---|---|---|
| Founded | 1988 | 2020 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2020 | 2022 |
| Metric | PHAR | ASST |
|---|---|---|
| Price | $11.57 | $12.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $38.33 | $23.50 |
| AVG Volume (30 Days) | 18.0K | ★ 2.6M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $633,489.00 |
| Revenue This Year | $10.04 | $294.91 |
| Revenue Next Year | $2.51 | $12.16 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | ★ 128.67 |
| 52 Week Low | $9.62 | $0.49 |
| 52 Week High | $21.34 | $19.75 |
| Indicator | PHAR | ASST |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 52.40 |
| Support Level | $9.62 | $10.85 |
| Resistance Level | $17.89 | $12.85 |
| Average True Range (ATR) | 0.67 | 0.71 |
| MACD | 0.15 | 0.15 |
| Stochastic Oscillator | 58.51 | 73.59 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Strive Inc is a structured finance company and institutional asset manager focused on disciplined capital allocation and long term value creation. The company has adopted bitcoin as its hurdle rate for capital deployment because of its fiduciary duty to maximize long-term value for stockholders, and compounding purchasing power over time. It operates in two reportable operating segments: the Asset Management segment, which provides investment advisory services and the Corporate & Other segment, which includes the company's bitcoin treasury operations. The majority of the revenue is derived from the Asset Management segment.